Trial Profile
AGe-adapted Benefits of Envarsus Versus Twice-daily Tacrolimus ImmunosuppressioN druGs After Kidney Transplantation (AGEING) - a Feasibility Study
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 11 Oct 2019
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Acronyms AGEING
- 03 Jan 2017 New trial record